Month: February 2024

Prof_Claude_Wischik

TauRx to Present Two-Year Data from Phase III Trial of HMTM in Alzheimer’s Disease at the AD/PD™ 2024 Conference in March

ABERDEEN, Scotland--(BUSINESS WIRE)--TauRx Pharmaceuticals Ltd., a global leader in Tau-based research in Alzheimer’s disease (AD), announced today that the company...

qritiveLOGO

Qritive Secures Multi-Year Contracts with Metropolis Healthcare, CÅŒRE Diagnostics and Rajiv Gandhi Cancer Institute to Drive AI Adoption in Pathology Across India

MUMBAI, India & SINGAPORE--(BUSINESS WIRE)--#AI--QritiveTM, a leading provider of AI solutions for pathology labs worldwide, announces partnership with esteemed diagnostic...